Medication Safety Alert! August 23, 2018
In this week’s issue:
- High-Alert Medication Survey Results Lead to Several Changes for 2018
- Rabies immune globulin vial sizes look similar
- Another imported potassium chloride for injection concentrate
- Methotrexate “Call to Action” brings results
- Standardization should result in improvements, not simply conformity
Between June and July 2018, ISMP conducted a survey on high-alert medications in acute care settings to learn about possible additions or deletions before updating our longstanding list. High-alert medications are an essential component of drug therapy, but they carry a significant risk of causing serious injuries or death to patients if they are misused. Errors with these products are not necessarily more common, but the consequences of an error are often quite harmful and can even be fatal.
ISMP published its first list of “high-alert” medications in 1989 (Davis NM, Cohen MR. Today’s...